The global Counterfeit Drug Detection Device Market is predicted to develop at a 4.0% CAGR from 2022 to 2029, with a market value of roughly US$ 1.14 billion in 2022. According to Future Market Insights, counterfeit chemical composition detection devices will account for approximately 60.6% of the global market in 2.
Counterfeit drugs are substandard and falsified drugs and it is a global problem. Counterfeit Drug Detection Devices are the medical devices that are used to detect the counterfeit chemical composition of the drugs and counterfeit packaging and labeling of the drug. The WHO defines a counterfeit drug as any pharmace.
Counterfeit drugs are substandard and falsified drugs and it is a global problem. Counterfeit Drug Detection Devices are the medical devices that are used to detect the counterfeit chemical composition of the drugs and counterfeit packaging and labeling of the drug. The WHO defines a counterfeit drug as any pharmace.
Global alliance unites pharma pros to battle counterfeiting Fight the Fakes gathers manufacturers and other stakeholders to brainstorm on ways to combat falsified medicines and safeguard the world’s medicine supply.
Pharmaceutical counterfeiting is a widespread, pervasive problem that impacts not only pharma companies, but anyone who finds themselves in need of medicines. The minds behind Fight the Fakes launched the organization to bring together industry colleagues to work toward ways to thwart counterfeiters wherever they may strike.
Outsourcing-Pharma (OSP) recently spoke with Adam Aspinall (AA) chair of the Fight the Fakes Alliance, as well as senior director of access and product management for the Medicines for Malaria Venture about global counterfeiting, the group’s mission, accomplishments to date, and how individuals may join the organization in its work.